APA (7th ed.) Citation

(2020). Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa.

Chicago Style (17th ed.) Citation

Multicenter Evaluation of Ceftolozane/tazobactam for Serious Infections Caused by Carbapenem-resistant Pseudomonas Aeruginosa. 2020.

MLA (8th ed.) Citation

Multicenter Evaluation of Ceftolozane/tazobactam for Serious Infections Caused by Carbapenem-resistant Pseudomonas Aeruginosa. 2020.

Warning: These citations may not always be 100% accurate.